SCHEMBL16827451

SCHEMBL16827451

CC(C)=CCc1ccc(Br)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PYCR1 P32322 1/20 0.43
▸ HTT P42858 4/20 0.39
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ AKR1B10 O60218 2/20 0.35
▸ AKR1B1 P15121 2/20 0.35
▸ AKR1C3 P42330 2/20 0.35
▸ MMP2 P08253 1/20 0.34
▸ PAK1 Q13153 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12496273 0.79 PYCR1 (0.43) PYCR1HTTMEN1KMT2AHPGD
SCHEMBL14139155 0.76 HTT (0.60) HTTMEN1KMT2AHPGDCYP1A2
SCHEMBL480186 0.76 PYCR1 (0.42) PYCR1HTTMEN1KMT2AHPGD
SCHEMBL8173928 0.76 LMNA (0.43) PYCR1HTTMEN1KMT2AHPGD
SCHEMBL7947654 0.74 SLC6A4 (0.46) HTTMEN1KMT2AHPGDCYP1A2
SCHEMBL28251094 0.73 IDO1 (0.45) HTTMEN1KMT2ACYP3A4SMN1; SMN2
SCHEMBL1350652 0.73 PYCR1 (0.44) PYCR1HTTMEN1KMT2AHPGD
SCHEMBL307760 0.72 PYCR1 (0.46) PYCR1HTTMEN1KMT2ASMN1; SMN2
SCHEMBL30467771 0.72 PYCR1 (0.46) PYCR1HTTMEN1KMT2ASMN1; SMN2
SCHEMBL257075 0.72 PYCR1 (0.50) PYCR1HTTMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015092634-A1 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS NOVARTIS AG (CH) 2015-06-25 — — WO disclosed
Send feedback